4 Einträge gefunden

1. Bimekizumab versus Secukinumab in Plaque Psoriasis

   1. Reich, Kristian
   2. Warren, Richard B
   3. Lebwohl, Mark
   4. Gooderham, Melinda
   5. Strober, Bruce
   6. Langley, Richard G
   7. Paul, Carle

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
2. Psychometric Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM): A Novel Patient-Reported Outcome Instrument for Patients with Plaque Psoriasis, Using Reported Data from the BE RADIANT Phase 3b Trial

   1. Gottlieb, Alice B
   2. Warren, Richard B
   3. Augustin, Matthias
   4. Garcia, Llenalia
   5. Cioffi, Christopher
   6. Peterson, Luke
   7. Pelligra, Christopher

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
3. Bimekizumab versus Adalimumab in Plaque Psoriasis

   1. Warren, Richard B
   2. Blauvelt, Andrew
   3. Bagel, Jerry
   4. Papp, Kim A
   5. Yamauchi, Paul
   6. Armstrong, April
   7. Langley, Richard G

   2021 - Forschungsinformationssystem des UKE
4. Bimekizumab versus ustekinumab for the treatment of moderate to severe plaque psoriasis (BE VIVID): efficacy and safety from a 52-week, multicentre, double-blind, active comparator and placebo controlled phase 3 trial

   1. Reich, Kristian
   2. Papp, Kim A
   3. Blauvelt, Andrew
   4. Langley, Richard G
   5. Armstrong, April
   6. Warren, Richard B
   7. Gordon, Kenneth B

   2021 - Forschungsinformationssystem des UKE